MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
3.590
-0.080
-2.18%
After Hours: 3.600 +0.01 +0.28% 19:43 12/16 EST
OPEN
3.630
PREV CLOSE
3.670
HIGH
3.740
LOW
3.560
VOLUME
1.02M
TURNOVER
--
52 WEEK HIGH
6.21
52 WEEK LOW
1.665
MARKET CAP
917.99M
P/E (TTM)
-4.2525
1D
5D
1M
3M
1Y
5Y
1D
Maravai LifeSciences Is Maintained at Overweight by Wells Fargo
Dow Jones · 1d ago
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $4.5
Benzinga · 1d ago
Maravai Lifesciences price target raised to $4.50 from $4 at Wells Fargo
TipRanks · 1d ago
Weekly Report: what happened at MRVI last week (1208-1212)?
Weekly Report · 1d ago
U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp
Reuters · 1d ago
Wednesday 12/10 Insider Buying Report: AVTR, MRVI
NASDAQ · 6d ago
Analysts Are Bullish on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Corvus Pharmaceuticals (CRVS)
TipRanks · 6d ago
After-Hours Rally: Stoke Therapeutics, Alpha Tau Medical, Compass Pathways Lead Biotech Movers
NASDAQ · 12/10 04:35
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.